The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 36

More Articles from The Primary Care Companion for CNS Disorders

PCC
Exploring the Addictive Nature of Fantasy Games Beyond Skill Mastery
Case Report

Exploring the Addictive Nature of Fantasy Games Beyond Skill Mastery

December 21, 2023

The rise of fantasy game culture has had a significant impact on society and has transformed the perception of gaming from a recreational activity to a legitimate career option.
, ,
PCC
Therapeutic Framework for Post–Suicide Attempt Family Meetings
Case Report

Therapeutic Framework for Post–Suicide Attempt Family Meetings

December 19, 2023

The authors propose a novel framework for the family meeting following a suicide attempt within the context of a patient case.
, ,
PCC
Efficacy and Safety of Loxapine in Acute Agitation
Systematic Review

Efficacy and Safety of Loxapine in Acute Agitation

December 19, 2023

Loxapine was found to be more effective and faster regarding acute agitation control and was well-tolerated, with mildly or moderately severe adverse effects.
, , , et al
PCC
Long-Term Preservation TMS for MDD
Case Report

Long-Term Preservation TMS for MDD

December 14, 2023

Two cases provide a unique look at how remission of depression can be maintained over a long duration using scheduled treatments of preservation transcranial magnetic stimulation with progressively increasing…
, , , et al
PCC
Urinary Retention: an Uncommon Adverse Effect of Venlafaxine
Case Report

Urinary Retention: an Uncommon Adverse Effect of Venlafaxine

December 14, 2023

This case highlights the need to consider urinary side effects while prescribing venlafaxine.
, , , et al
PCC
Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients
Brief Report

Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients

December 12, 2023

The South Florida Cognitive Screener is an 8-item self-report instrument developed to capture the most common cognitive, functional, and behavioral complaints typically reported early in the process of cognitive…
, , , et al
PCC
Shared or Induced Olfactory Reference Syndrome
Case Report

Shared or Induced Olfactory Reference Syndrome

December 7, 2023

Olfactory reference syndrome (ORS) is an underrecognized condition characterized by preoccupation with body odor accompanied by significant distress and functional impairment This is a case of 2 sisters with…
,
PCC
Cefepime-Induced Cotard Syndrome
Case Report

Cefepime-Induced Cotard Syndrome

December 7, 2023

Cefepime neurotoxicity is a well-documented though underrecognized cause of encephalopathy. This report describes a case of cefepime-induced Cotard syndrome, a rare delusional syndrome marked by a belief that one…
, , , et al
PCC
Benzodiazepines Prescribed With and Without Opioids
Brief Report

Benzodiazepines Prescribed With and Without Opioids

December 5, 2023

This study analyzed the National Ambulatory Medical Care Survey to calculate recent changes in rates of benzodiazepine prescription after the release of the CDC guidelines for prescribing opioids for…
, ,
PCC
Psychopathological Effects of Solitary Confinement
Case Report

Psychopathological Effects of Solitary Confinement

November 30, 2023

There appears to be a correlation between solitary confinement and mental illness with variable effects based on underlying history, length of confinement, and treatment during confinement.
, , , et al
PCC
Vinegar-Induced Disulfiram Reaction
Case Report

Vinegar-Induced Disulfiram Reaction

November 30, 2023

A patient on disulfiram treatment developed erythematous plaques and papules after consumption of noodles containing vinegar.
,
PCC
Mild Cognitive Impairment and Early Alzheimer’s Disease Management and the Role of New Treatments
Rounds in the General Hospital

Mild Cognitive Impairment and Early Alzheimer’s Disease Management and the Role of New Treatments

November 28, 2023

Monoclonal antibodies have shown some promise for slowing cognitive decline and adverse brain changes in mild cognitive impairment and early Alzheimer’s disease, though risks and anticipated benefits will be…
, , , et al

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe